Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques

References

• Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–276.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functi. Circulation. 2006;113:1807–1816.
   PubMed Web of Science ®Google Scholar
• Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390:400–414.
   PubMed Web of Science ®Google Scholar
• McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121:731–748.
   PubMed Web of Science ®Google Scholar
• Pinto YM, Elliott PM, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–1858.
   PubMed Web of Science ®Google Scholar
• Thomas DE, Wheeler R, Yousef ZR, et al. The role of echocardiography in guiding management in dilated cardiomyopathy. Eur J Echocardiogr. 2009;15–21. DOI:10.1093/ejechocard/jep158
   Web of Science ®Google Scholar
• Marques JS, Pinto FJ. Clinical use of multimodality imaging in the assessment of dilated cardiomyopathy. Heart. 2015;101:565–572.
   PubMed Web of Science ®Google Scholar
• Francone M. Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance. ISRN Radiol. 2014;(2014):1–16.
   Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–270.
   PubMed Web of Science ®Google Scholar
• O’Gara PT, Grayburn PA, Badhwar V, et al. 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American college of cardiology task force on expert consensus decision pathways. J Am Coll Cardiol. 2017;70:2421–2449.
   PubMed Web of Science ®Google Scholar
• Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675–1680.
   PubMed Web of Science ®Google Scholar
• Merlo M, Cannata A, Gobbo M, et al. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20:228–239.
   PubMed Web of Science ®Google Scholar
• Japp AG, Gulati A, Cook SA, et al. Evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67:2996–3010.
   PubMed Web of Science ®Google Scholar
• Merlo M, Caiffa T, Gobbo M, et al. Reverse remodeling in dilated cardiomyopathy: insights and future perspectives. IJC Hear Vasc. 2018;18:52–57.
   PubMed Web of Science ®Google Scholar
• Merlo M, Pyxaras SA, Pinamonti B, et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011;57:1468–1476.
   PubMed Web of Science ®Google Scholar
• Merlo M, Gobbo M, Stolfo D, et al. The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging. 2016;9:1034–1042.
   PubMed Web of Science ®Google Scholar
• Pinamonti B, Di Lenarda A, Sinagra G, et al. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993;22:808–815.
   PubMed Web of Science ®Google Scholar
• Pinamonti B, Zecchin M, Di Lenarda A, et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997;29:604–612.
   PubMed Web of Science ®Google Scholar
• Dini FL, Cortigiani L, Baldini U, et al. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol. 2002;89:518–523.
   PubMed Web of Science ®Google Scholar
• Negishi K, Negishi T, Hare JL, et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013;26:493–498.
   PubMed Web of Science ®Google Scholar
• Merlo M, Stolfo D, Anzini M, et al. Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? J Am Heart Assoc. 2015;4:e001504.
   PubMed Web of Science ®Google Scholar
• Adamo L, Perry A, Novak E, et al. Abnormal global longitudinal strain predicts future deterioration of left ventricular function in heart failure patients with a recovered left ventricular ejection fraction. Circ Heart Fail. 2017;10. DOI:10.1161/CIRCHEARTFAILURE.116.003788
   PubMed Web of Science ®Google Scholar
• Carluccio E, Biagioli P, Alunni G, et al. Prognostic value of right ventricular dysfunction in heart failure with reduced ejection fraction: superiority of longitudinal strain over tricuspid annular plane systolic excursion. Circ Cardiovasc Imaging. 2018;11:e006894.
   PubMed Web of Science ®Google Scholar
• Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to crt (prospect) trial. Circulation. 2008;117:2608–2616.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Nesser HJ, Buck T, et al. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J. 2010;31:1690–1700.
   PubMed Web of Science ®Google Scholar
• Haugaa KH, Goebel B, Dahlslett T, et al. Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography. J Am Soc Echocardiogr. 2012;25:667–673.
   PubMed Web of Science ®Google Scholar
• Kapetanakis S, Bhan A, Murgatroyd F, et al. Real-time 3D echo in patient selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2011;4:16–26.
   PubMed Web of Science ®Google Scholar
• Ruddox V, Mathisen M, Bækkevar M, et al., Is 3D echocardiography superior to 2D echocardiography in general practice? A systematic review of studies published between 2007 and 2012. Int J Cardiol. 2013;168:1306–1315.
   PubMed Web of Science ®Google Scholar
• Moretti M, Merlo M, Barbati G, et al. Prognostic impact of familial screening in dilated cardiomyopathy. Eur J Heart Fail. 2010;12:922–927.
   PubMed Web of Science ®Google Scholar
• Fatkin D, Yeoh T, Hayward CS, et al. Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy. Circ Cardiovasc Genet. 2011;4:342–348.
   PubMed Web of Science ®Google Scholar
• Lakdawala NK, Thune JJ, Colan SD, et al. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy. Circ Cardiovasc Genet. 2012;5:503–510.
   PubMed Web of Science ®Google Scholar
• Strohm O, Schulz-Menger J, Pilz B, et al. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging. 2001;13:367–371.
   PubMed Web of Science ®Google Scholar
• Iles LM, Ellims AH, Llewellyn H, et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging. 2015;16:14–22.
   PubMed Web of Science ®Google Scholar
• Schalla S, Bekkers SC, Dennert R, et al. Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail. 2010. DOI:10.1093/eurjhf/hfq004
   PubMed Web of Science ®Google Scholar
• McCrohon JA, Moon JCC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59.
   PubMed Web of Science ®Google Scholar
• de Leeuw N, Ruiter DJ, Balk AH, et al. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transplant Int. 2001;14:299–306.
   PubMed Web of Science ®Google Scholar
• Soriano CJ, Ridocci F, Estornell J, et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol. 2005;45:743–748.
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–1474.
   PubMed Web of Science ®Google Scholar
• Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015;36:1445–1453.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475–484.
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Malipiero G, Marcolongo R, et al. Myocarditis: a clinical overview. Curr. Cardiol. Rep. 2017;19:63.
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53:1475–1487.
   PubMed Web of Science ®Google Scholar
• Francone M, Chimenti C, Galea N, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging. 2014;7:254–263.
   PubMed Web of Science ®Google Scholar
• Ferreira VM, Piechnik SK, Dall’Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6:1048–1058.
   PubMed Web of Science ®Google Scholar
• Pan JA, Lee YJ, Salerno M. Diagnostic performance of extracellular volume, native T1, and T2 mapping versus lake louise criteria by cardiac magnetic resonance for detection of acute myocarditis: a meta-analysis. Circ Cardiovasc Imaging. 2018;11:e007598.
   PubMed Web of Science ®Google Scholar
• Te Riele ASJM, Tandri H, Bluemke DA. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. J Cardiovasc Magn Reson. 2014;16:50.
   PubMed Web of Science ®Google Scholar
• Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J. 2010;31:806–814.
   PubMed Web of Science ®Google Scholar
• Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376:61–72.
   PubMed Web of Science ®Google Scholar
• Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005;45:98–103.
   PubMed Web of Science ®Google Scholar
• Rapezzi C, Lorenzini M, Longhi S, et al. Cardiac amyloidosis: the great pretender. Heart Fail Rev. 2015;20:117–124.
   PubMed Web of Science ®Google Scholar
• Banypersad SM, Sado DM, Flett AS, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging. 2013;6:34–39.
   PubMed Web of Science ®Google Scholar
• White JA, Kim HW, Shah D, et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:143–156.
   PubMed Web of Science ®Google Scholar
• Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51:1022–1030.
   PubMed Web of Science ®Google Scholar
• Birnie D.H, Nery P.B, Ha R.S.B. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68:411–421.
   PubMed Web of Science ®Google Scholar
• Smedema J-P, Snoep G, van Kroonenburgh MPG, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683–1690.
   PubMed Web of Science ®Google Scholar
• Smedema J-P, Snoep G, van Kroonenburgh MPG, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest. 2005;128:1629–1637.
   PubMed Web of Science ®Google Scholar
• Ichinose A, Otani H, Oikawa M, et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol. 2008;191:862–869.
   PubMed Web of Science ®Google Scholar
• Cummings KW, Bhalla S, Javidan-Nejad C, et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics. 2009;29:89–103.
   PubMed Web of Science ®Google Scholar
• Murtagh G, Laffin LJ, Beshai JF, et al. Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2016;9:e003738.
   PubMed Web of Science ®Google Scholar
• Dweck MR, Abgral R, Trivieri MG, et al. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc Imaging. 2018;11:94–107.
   PubMed Web of Science ®Google Scholar
• Fernandez-Golfin C, Pachon M, Corros C, et al. Left ventricular trabeculae: quantification in different cardiac diseases and impact on left ventricular morphological and functional parameters assessed with cardiac magnetic resonance. J Cardiovasc Med (Hagerstown). 2009;10:827–833.
   PubMed Web of Science ®Google Scholar
• Jacquier A, Thuny F, Jop B, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010;31:1098–1104.
   PubMed Web of Science ®Google Scholar
• Negri F, De Luca A, Morea G, et al. [Make a point on left ventricular noncompaction]. G Ital Cardiol (Rome). 2018;19:371–378.
   PubMedGoogle Scholar
• Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945–1953.
   PubMed Web of Science ®Google Scholar
• Leong DP, Chakrabarty A, Shipp N, et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. Eur Heart J. 2012;33:640–648.
   PubMed Web of Science ®Google Scholar
• Leyva F, Taylor RJ, Foley PWX, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:1659–1667.
   PubMed Web of Science ®Google Scholar
• Becker MAJ, Cornel JH, van de Ven PM, et al. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC Cardiovasc Imaging. 2018. DOI:10.1016/j.jcmg.2018.03.006
   PubMed Web of Science ®Google Scholar
• Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57:821–828.
   PubMed Web of Science ®Google Scholar
• Grani C, Eichhorn C, Biere L, et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol. 2017;70:1964–1976.
   PubMed Web of Science ®Google Scholar
• Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221–1230.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer. J Card Fail. 2017;23(2017):628–651.
   PubMedGoogle Scholar
• Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the Euro. G Ital Cardiol (Rome). 2016;17:108–170.
   PubMedGoogle Scholar
• Lakdawala NK, Givertz MM. Dilated cardiomyopathy with conduction disease and arrhythmia. Circulation. 2010;122:527–534.
   PubMed Web of Science ®Google Scholar
• Di Marco A, Anguera I, Schmitt M, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail. 2017;5:28–38.
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American heart association. Circulation. 2016;134:e579–e646.
   PubMed Web of Science ®Google Scholar
• Gulati A, Ismail TF, Jabbour A, et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation. 2013;128:1623–1633.
   PubMed Web of Science ®Google Scholar
• Halliday BP, Gulati A, Ali A, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135:2106–2115.
   PubMed Web of Science ®Google Scholar
• Merlo M, Cannata A, Vitagliano A, et al. Clinical management of dilated cardiomyopathy: current knowledge and future perspectives. Expert Rev Cardiovasc Ther. 2016;14:137–140.
   PubMed Web of Science ®Google Scholar
• Salerno M, Sharif B, Arheden H, et al. Recent advances in cardiovascular magnetic resonance: techniques and applications. Circ Cardiovasc Imaging. 2017;10. DOI:10.1161/CIRCIMAGING.116.003951.
   Web of Science ®Google Scholar
• Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging. 2012;5:102–110.
   PubMed Web of Science ®Google Scholar
• Tanner MA, Galanello R, Dessi C, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007;115:1876–1884.
   PubMed Web of Science ®Google Scholar
• Luetkens JA, Homsi R, Sprinkart AM, et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging. 2016;17:154–161.
   PubMed Web of Science ®Google Scholar
• Kuruvilla S, Janardhanan R, Antkowiak P, et al. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging. 2015;8:172–180.
   PubMed Web of Science ®Google Scholar
• Gunaratnam K, Wong LH, Nasis A, et al. Review of cardiomyopathy imaging. Eur J Radiol. 2013;82:1763–1775.
   PubMed Web of Science ®Google Scholar
• Elfigih IA, Henein MY. Non-invasive imaging in detecting myocardial viability: myocardial function versus perfusion. IJC Hear Vasc. 2014;5:51–56.
   PubMedGoogle Scholar
• Rapezzi C, Arbustini E, Caforio ALP, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2013;34:1448–1458.
   PubMed Web of Science ®Google Scholar
• Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995;107:330–334.
   PubMed Web of Science ®Google Scholar
• Hulten E, Aslam S, Osborne M, et al. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6:50–63.
   PubMed Web of Science ®Google Scholar
• Perugini E, Guidalotti PL, Salvi F, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46:1076–1084.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412.
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Kindermann I, Kindermann M, et al. Endomyocardial biopsy differences in complication rate and diagnostic performance. Circulation. 2010;9:900–909.
   Google Scholar
• Bennett MK, Gilotra NA, Harrington C, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009. Circ Heart Fail. 2013;6:676–684.
   PubMed Web of Science ®Google Scholar
• Sinagra G, Anzini M, Pereira NL, et al. Myocarditis in clinical practice. Mayo Clin Proc. 2016;91:1256–1266.
   PubMed Web of Science ®Google Scholar
• Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res. 2003;60:11–25.
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250–1258.
   PubMed Web of Science ®Google Scholar
• Mathew T, Williams L, Navaratnam G, et al. Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography. Echo Res Pract. 2017;4:G1–G13.
   PubMed Web of Science ®Google Scholar
• Merlo M, Porcari A, Sinagra G. The (ultra) sound of a burning heart: a matter of speckles. Int J Cardiol. 2018;259:132–133.
   PubMed Web of Science ®Google Scholar
• Merlo M, Mase M, Vitrella G, et al. Usefulness of addition of magnetic resonance imaging to echocardiographic imaging to predict left ventricular reverse remodeling in patients with nonischemic cardiomyopathy. Am J Cardiol. 2018. DOI:10.1016/j.amjcard.2018.04.017
   Google Scholar